Funded Startups in Uppsala
The largest disclosed round in this Uppsala-focused list is Metacon AB’s $60M on 2026-04-16 (Series Unknown).
The largest disclosed round in this Uppsala-focused list is Metacon AB’s $60M on 2026-04-16 (Series Unknown). That $60M figure stands out against the rest of the disclosed amounts shown: aside from $17M (OssDsign AB on 2025-06-03) and $10M (Metacon AB on 2024-02-19), most other disclosed rounds cluster far lower, including multiple rounds at $3M ($3M for Klaria Pharma Holding on 2026-06-05; Beactica Therapeutics AB on 2026-02-17; Gradientech on 2024-10-09).
The dataset also shows a tight temporal run-up: 4 of 14 rows have round dates in 2026 (2026-02-17 through 2026-06-26), and several additional entries fall in 2024 (2024-10-09 through 2024-10-10, plus 2024-02-19). Sector-wise, Biotechnology appears 5 times across the rows (Bio-Works, Beactica Therapeutics AB, OssDsign AB, Gradientech, Rarity Bioscience, plus Synartro), while Health Care appears twice (Klaria Pharma Holding and Beactica Therapeutics AB) and agriculture/farming appears twice (AirForestry and NitroCapt). Stages are also skewed toward “Series Unknown” classifications (5 of 14), with one explicit Seed round dated 2026-10-10 absent; more concretely, one entry is “undisclosed” (PeptiSystems, 2025-11-12).
Most recent rounds
14 shownRelated listings
Frequently asked
What is the largest disclosed round in this Uppsala set, and how does it compare to the next-highest disclosed amounts?
Metacon AB’s $60M on 2026-04-16 is the only disclosed round above $50M. The next-highest disclosed amounts are $17M (OssDsign AB on 2025-06-03) and $10M (Metacon AB on 2024-02-19), putting the $60M round in a distinctly higher tier than the rest of the disclosed figures shown.
Do the most recent round dates cluster, or are they spread evenly across years?
They cluster near the top end of the timeline: 4 of 14 rounds are dated in 2026 (2026-02-17, 2026-04-16, 2026-06-05, 2026-06-26). Beyond that, 2024 also concentrates multiple entries, including two consecutive dates in October 2024 (Gradientech on 2024-10-09 and AirForestry on 2024-10-10).
Which sectors are most represented in these 14 rows?
Biotechnology appears in 5 rows: Bio-Works (2026-04-16), Beactica Therapeutics AB (2026-02-17), OssDsign AB (2025-06-03), Gradientech (2024-10-09), and Rarity Bioscience (2023-02-06). Health Care appears twice (Klaria Pharma Holding on 2026-06-05 and Beactica Therapeutics AB on 2026-02-17), while agriculture/farming appears twice (AirForestry on 2024-10-10 and NitroCapt on 2022-02-01).
How much of the list uses unknown or undisclosed round sizing, and does that change the “largest” comparisons?
Round size is “undisclosed” for PeptiSystems on 2025-11-12, and “Series Unknown” appears for 5 of 14 rows. The largest/next-largest comparisons rely only on disclosed amounts, where Metacon AB’s $60M (2026-04-16) remains the clear outlier versus the disclosed $17M and $10M entries.
Are there notable outliers by stage or deal size within this Uppsala sample?
Deal sizes show a sharp outlier: Metacon AB’s $60M on 2026-04-16 dwarfs the other disclosed rounds, with several at $3M (Klaria Pharma Holding on 2026-06-05; Beactica Therapeutics AB on 2026-02-17; Gradientech on 2024-10-09). Stage-wise, Seed appears explicitly for AirForestry ($9M on 2024-10-10), Rarity Bioscience ($540K on 2023-02-06), and Peafowl Plasmonics ($4M on 2022-04-27), but many other entries remain “Series Unknown.”
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.